Utah Medical Products Form 8-K October 05, 2005

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 

Date of Report (date of earliest event reported): October 5, 2005


Commission File No. 0-11178


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


UTAH
87-0342734
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)


7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices


Registrant's telephone number:     (801) 566-1200

 
 
 
 

ITEM 8.01 OTHER EVENTS
 
 
On October 5, 2005, Utah Medical Products, Inc. issued a press release announcing that its FDA trial had concluded. A copy of the press release is attached hereto as Exhibit 99.1


SIGNATURES
 

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
     
     
Date:                     10/5/05                         
By:
    /s/ Kevin L. Cornwell
   
Kevin L. Cornwell
   
CEO




EXHIBIT INDEX



Index
Number
Description
   
99.1
Press release issued October 5, 2005: Utah Medical Products, Inc.: FDA Trail Concluded